Literature DB >> 3049136

Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome.

J Krieger1, D Kurtz.   

Abstract

Compliance with nasal continuous positive airway pressure (CPAP) has become a major concern, since this treatment is efficacious, but constraining. In 46 consecutive obstructive sleep apnoea (OSA) patients, we measured compliance with nasal CPAP by establishing a mean rate of use, with a built-in time counter read at three-month intervals, over a mean follow-up period of 232 +/- 27 days. The mean rate of use in the whole group was 5.14 +/- 0.31 hours per day. The acceptance rate was 90.9-93.2%, showing that patient acceptance is not a limitation in the use of nasal CPAP.

Entities:  

Mesh:

Year:  1988        PMID: 3049136

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  10 in total

Review 1.  CPAP therapy: outcomes and patient use.

Authors:  N J Douglas; H M Engleman
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Improving compliance with nasal CPAP and vigilance in older adults with OAHS.

Authors:  M S Aloia; L Di Dio; N Ilniczky; M L Perlis; D W Greenblatt; D E Giles
Journal:  Sleep Breath       Date:  2001       Impact factor: 2.816

Review 3.  Temperature controlled radiofrequency ablation at different sites for treatment of obstructive sleep apnea syndrome: a systematic review and meta-analysis.

Authors:  Ridhwan Y Baba; Arjun Mohan; V V S Ramesh Metta; M Jeffery Mador
Journal:  Sleep Breath       Date:  2015-02-03       Impact factor: 2.816

Review 4.  Sleep-related breathing disorders. 5. Nasal continuous positive airway pressure treatment for obstructive sleep apnoea.

Authors:  R R Grunstein
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

Review 5.  Cardiovascular implications in the treatment of obstructive sleep apnea.

Authors:  Olivier M Vanderveken; An Boudewyns; Quan Ni; Bhavani Kashyap; Johan Verbraecken; Wilfried De Backer; Paul Van de Heyning
Journal:  J Cardiovasc Transl Res       Date:  2010-11-20       Impact factor: 4.132

6.  Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; S E Martin; N J Douglas
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

7.  Nasal breathing and continuous positive airway pressure (CPAP) in patients with obstructive sleep apnea (OSA).

Authors:  Jan H Hollandt; Malte Mahlerwein
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

Review 8.  Oral appliance treatment for obstructive sleep apnea: an update.

Authors:  Kate Sutherland; Olivier M Vanderveken; Hiroko Tsuda; Marie Marklund; Frederic Gagnadoux; Clete A Kushida; Peter A Cistulli
Journal:  J Clin Sleep Med       Date:  2014-02-15       Impact factor: 4.062

Review 9.  Clinical features and treatment of obstructive sleep apnea.

Authors:  R J Kimoff; M G Cosio; M McGregor
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

10.  Objective measurement of compliance during oral appliance therapy for sleep-disordered breathing.

Authors:  Olivier M Vanderveken; Marijke Dieltjens; Kristien Wouters; Wilfried A De Backer; Paul H Van de Heyning; Marc J Braem
Journal:  Thorax       Date:  2012-09-19       Impact factor: 9.139

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.